These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 30900424)

  • 1. A Feasibility Study for Diagnosis of Latent Tuberculosis Infection Using an IGRA Point-of-Care Platform in South Korea.
    Hur YG; Hong JY; Choi DH; Kim A; Park SY; Kwon M; Kang K; Lee JM; Dockrell HM; Lee Y; Joo H; Cho SN
    Yonsei Med J; 2019 Apr; 60(4):375-380. PubMed ID: 30900424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a lateral flow assay-based IFN-γ release assay as a point-of-care test for the diagnosis of latent tuberculosis infection.
    Lee HH; Choi DH; Kim JR; Kim YG; Jo KW; Shim TS
    Clin Rheumatol; 2021 Sep; 40(9):3773-3781. PubMed ID: 33666781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
    Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F
    BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Standard E TB-Feron Enzyme-Linked Immunosorbent Assay for Diagnosis of Latent Tuberculosis Infection in Health Care Workers.
    Kweon OJ; Lim YK; Kim HR; Kim TH; Lee MK
    J Clin Microbiol; 2019 Dec; 57(12):. PubMed ID: 31533984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QuantiFERON-TB Gold Plus combined with HBHA-Induced IFN-γ release assay improves the accuracy of identifying tuberculosis disease status.
    Tang J; Huang Y; Jiang S; Huang F; Ma T; Qi Y; Ma Y
    Tuberculosis (Edinb); 2020 Sep; 124():101966. PubMed ID: 32866942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Accuracy of Early Secretory Antigenic Target-6-Free Interferon-gamma Release Assay Compared to QuantiFERON-TB Gold In-tube.
    Nemes E; Abrahams D; Scriba TJ; Ratangee F; Keyser A; Makhethe L; Erasmus M; Mabwe S; Bilek N; Rozot V; Geldenhuys H; Hatherill M; Lempicki MD; Holm LL; Bogardus L; Ginsberg AM; Blauenfeldt T; Smith B; Ellis RD; Loxton AG; Walzl G; Andersen P; Ruhwald M
    Clin Infect Dis; 2019 Oct; 69(10):1724-1730. PubMed ID: 30668657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance Evaluation of a New Automated Chemiluminescent Immunoanalyzer-Based Interferon-Gamma Releasing Assay AdvanSure I3 in Comparison With the QuantiFERON-TB Gold In-Tube Assay.
    Kim JJ; Park Y; Choi D; Kim HS
    Ann Lab Med; 2020 Jan; 40(1):33-39. PubMed ID: 31432637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube Interferon Gamma Release Assays in Patients at Risk for Tuberculosis and in Health Care Workers.
    Theel ES; Hilgart H; Breen-Lyles M; McCoy K; Flury R; Breeher LE; Wilson J; Sia IG; Whitaker JA; Clain J; Aksamit TR; Escalante P
    J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29743310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Mycobacterium tuberculosis infection as measured by the QuantiFERON-TB Gold assay and ESAT-6 free IGRA among adolescents in Mwanza, Tanzania.
    Jeremiah K; Lyimo E; Ritz C; PrayGod G; Rutkowski KT; Korsholm KS; Ruhwald M; Tait D; Grewal HMS; Faurholt-Jepsen D
    PLoS One; 2021; 16(6):e0252808. PubMed ID: 34097715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Results of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus Assays for Detection of Tuberculosis Infection in Clinical Samples.
    Won D; Park JY; Kim HS; Park Y
    J Clin Microbiol; 2020 Mar; 58(4):. PubMed ID: 31969422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response.
    Butera O; Chiacchio T; Carrara S; Casetti R; Vanini V; Meraviglia S; Guggino G; Dieli F; Vecchi M; Lauria FN; Marruchella A; Laurenti P; Singh M; Caccamo N; Girardi E; Goletti D
    BMC Infect Dis; 2009 Nov; 9():182. PubMed ID: 19930588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
    Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants.
    O'Shea MK; Fletcher TE; Beeching NJ; Dedicoat M; Spence D; McShane H; Cunningham AF; Wilson D
    PLoS One; 2014; 9(5):e97366. PubMed ID: 24816576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of concordance of new QuantiFERON-TB Gold Plus platforms for
    Ruiz-Tagle C; García P; Hernández M; Balcells ME
    Microbiol Spectr; 2024 Aug; 12(8):e0046924. PubMed ID: 38975791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Evaluation of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus in Diagnosis of Latent Tuberculosis Infection in Immunocompromised Patients.
    Ryu MR; Park MS; Cho EH; Jung CW; Kim K; Kim SJ; Oh HY; Huh W; Jang HR; Koh WJ; Park HY; Kim YH; Sinn DH; Choi JO; Joh JW; Kim JM; Kim SJ; Park JB; Kang ES
    J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30135226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in interferon-γ production between QFT-Plus and QFT-GIT assays in TB contact investigation.
    Tsuyuzaki M; Igari H; Okada N; Suzuki K
    Respir Investig; 2019 Nov; 57(6):561-565. PubMed ID: 31402331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
    Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
    BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of isoniazid therapy for latent TB infection on QuantiFERON-TB gold in-tube responses in adults with positive tuberculin skin test results in a high TB incidence area: a controlled study.
    Johnson JL; Geldenhuys H; Thiel BA; Toefy A; Suliman S; Pienaar B; Chheng P; Scriba T; Boom WH; Hanekom W; Hatherill M
    Chest; 2014 Mar; 145(3):612-7. PubMed ID: 24135768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Analysis of Gamma Interferon Release Assay Response in Children with Latent and Active Tuberculosis.
    Lombardi G; Petrucci R; Corsini I; Bacchi Reggiani ML; Visciotti F; Bernardi F; Landini MP; Cazzato S; Dal Monte P
    J Clin Microbiol; 2018 Feb; 56(2):. PubMed ID: 29142046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.